![]() |
|
|
Radiation Biology Branch, National Cancer Institute, Bethesda, MD 20892
2To whom correspondence should be addressed. E-mail: jbm{at}helix.nih.gov.
KEY WORDS: functional imaging hypoxia redox imaging electron paramagnetic resonance imaging
| EXPANDED ABSTRACT |
|---|
|
|
|---|
Emerging developments in MRI add a functional and/or physiological dimension to anatomical images. Noninvasive imaging techniques currently are under development to provide tissue oxygen concentration and redox status information. Such technologies have the potential to aid physicians before, during, and after a course of therapy to prognosticate tumor and normal tissue biology, predict response to therapy, and guide therapeutic strategy throughout treatment. Overhauser MRI (OMRI) utilizes the enhancement of proton MRI images by a nontoxic free radical contrast agent. The advantages of this technique are the very low magnetic fields employed and its capability to provide quantitative information of tissue oxygen concentration (2). Using OMRI, we demonstrated recently that spatially resolved oxygen levels in a 1-cm diameter SCCVII mouse tumor are heterogeneous, with regions of hypoxia (<10 mm Hg) (3). The spatial and temporal resolution was
1 mm and 2 min, respectively. Oxygenation of tumors was enhanced upon carbogen inhalation. The oxygen measurements from OMRI were in agreement with those obtained by independent polarographic measurements using an Eppendorf oxygen electrode.
Tissue redox studies are performed using electron paramagnetic resonance imaging (EPRI), where the rate of nitroxide (free radical spin probe) reduction to the EPRI silent hydroxylamine is recorded spatially and reconstructed into a "tissue redox map" (46). We have recently shown that the redox map of SCCVII tumors is heterogeneous and that depletion of cellular glutathione in SCCVII tumors yields decreased nitroxide reduction capability and a shift in the redox map (4). Both OMRI and EPRI are promising noninvasive imaging technologies that can be used to better understand tumor and normal tissue physiology and perhaps better define conditions involving oxidative stress.
| FOOTNOTES |
|---|
| LITERATURE CITED |
|---|
|
|
|---|
1. Hockel, M., Schlenger, K., Aral, B., Mitze, M., Schaffer, U. & Vaupel, P. (1996) Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res 56:4509-4515.
2. Golman, K., Leunbach, I., Ardenkjaer-Larsen, J. H., Ehnholm, G. J., Wistrand, L. G., Petersson, J. S., Jarvi, A. & Vahasalo, S. (1998) Overhauser-enhanced MR imaging (OMRI). Acta Radiol. 39:10-17.[Medline]
3. Krishna, M. C., English, S., Yamada, K., Yoo, J., Murugesan, R., Devasahayam, N., Cook, J. A., Golman, K. & Ardenkjaer-Larsen, J. H., et al (2002) Overhauser enhanced magnetic resonance imaging for tumor oximetry: coregistration of tumor anatomy and tissue oxygen concentration. Proc. Natl. Acad. Sci. 99:2216-2221.
4. Kuppusamy, P., Li, H., Ilangovan, G., Cardounci, A. J., Zweier, J. L., Yamada, K., Krishna, M. C. & Mitchell, J. B. (2002) Noninvasive imaging of tumor redox status and its modification by tissue glutathione levels. Cancer Res 62:307-312.
5. Yamada, K. I., Kuppusamy, P., English, S., Yoo, J., Irie, A., Subramanian, S., Mitchell, J. B. & Krishna, M. C. (2002) Feasibility and assessment of non-invasive in vivo redox status using electron paramagnetic resonance imaging. Acta Radiol 43:433-440.[Medline]
6. Ilangovan, G., Li, H., Zweier, J. L., Krishna, M. C., Mitchell, J. B. & Kuppasamy, P. (2002) In vivo measurement of regional oxygenation and imaging of redox status in RIF-1 murine tumor: effect of carbogen-breathing. Magn. Reson. Med. 48:723-730.[Medline]
This article has been cited by other articles:
![]() |
A. P. Cotrim, A. L. Sowers, B. M. Lodde, J. M. Vitolo, A. Kingman, A. Russo, J. B. Mitchell, and B. J. Baum Kinetics of Tempol for Prevention of Xerostomia Following Head and Neck Irradiation in a Mouse Model Clin. Cancer Res., October 15, 2005; 11(20): 7564 - 7568. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. E. Seifried, D. E. Anderson, B. C. Sorkin, and R. B. Costello Executive Summary Report J. Nutr., November 1, 2004; 134(11): 3143S - 3163S. [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||